95608-6
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection
Active
Term Description
Qualitative results for the detection of SARS coronavirus 2 (SARS-CoV-2) in respiratory specimens by nucleic acid amplification with non-probe based detection, such as melt curve analysis or MALDI-TOF mass spectrometry. Results may be based on multiple assays to determine the presence of the virus in a specimen. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
LOINC Names Get Info
- Fully-Specified Name
- SARS coronavirus 2 RNA:
PrThr: Pt: Respiratory System Specimen: Ord: Non-probe.amp.tar - Long Common Name
- SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection
- Short Name
- SARS-CoV-2 RNA Resp Ql NAA+n-prb
- Display Name
- SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Respiratory system specimen)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19), Respiratory system specimen
Part Model Get Info
- Component
- SARS coronavirus 2 RNA
LP417541-2
- Analyte
- SARS coronavirus 2 RNA
LP417541-2
- Component Numerator
- SARS coronavirus 2 RNA
LP417541-2
- Component Numerator Core
- SARS coronavirus 2
LP417540-4
- Component Numerator Core Suffix
- RNA
LP32423-3
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Respiratory System Specimen
LP436142-6
- System Core
- Respiratory System Specimen
LP436142-6
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- Non-probe.amp.tar
LP208998-7
Example Answer List: LL5508-8
Source: Centers for Disease Control and Prevention| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 | ||
| InconclusiveCopyright http://snomed.info/sct ID:419984006 Inconclusive (qualifier value) | LA9663-1 | ||
| InvalidCopyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.82 (MIN)
- Change Reason
- Release 2.75: SYSTEM: There are 2 similar system's in LOINC: 1- Respiratory system 2- Respiratory specimen Due to an applied logic, the display in the System axis for 1 is Respiratory (adjective) without specification of sample, specimen, or other specific noun, while 2 is displayed fully as Respiratory specimen. Therefore for now we replaced 1 with Respiratory system specimen, which will affect 83 term. The result is replacing "Respiratory" with "Respiratory system specimen". This is the short approach. The bigger project is to potentially merge data that has either 1 or 2 together. This is a project to pass by the laboratory committee and will involve about 1500 concepts.;
- Order vs. Observation
- Both
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG50983-2 | SARS coronavirus 2 RNA| |
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | SARS-CoV-2 (COVID-19) RNA: |
| de-DE | German (Germany) | SARS-Coronavirus 2 RNA: |
| el-GR | Greek (Greece) | Κορωνοϊός SARS 2 RNA: Synonyms: MICRO Ord PrThr Pt RNA Αναπνευστικό Αναπνευστικό σύστημα Ανιχνευτής Ανιχνευτής.ενίσχυση Ανιχνευτής.ενίσχυση.στόχου Δείγμα Δείγμα αναπνευστικού συστήματος Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2 Χωρίς ανιχνευτή.ενίσχυση.στόχου |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) RNA: Synonyms: Muestra del tracto respiratorio Muestra respiratoria Tracto respiratorio |
| es-MX | Spanish (Mexico) | ARN del coronavirus 2 del SARS: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 ARN: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS ARN: |
| it-IT | Italian (Italy) | SARS coronavirus 2 RNA: Synonyms: Amplificazione target non basata su sonda Campione da Apparato Respiratorio Coronavirus della SARS Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA |
| pl-PL | Polish (Poland) | SARS-CoV-2 RNA: Synonyms: amplifikacja kwasu nukleinowego z detekcją bez użycia sondy amplifikacja kwasu nukleinowego z detekcją za pomocą sondy amplifikacja z detekcją za pomocą sondy Koronawirus |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 RNA: Synonyms: 2019 新型冠状病毒; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://